Breast Cancer Research
Breast Cancer Research
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.
Clinical Trials
Women In Steady Exercise Research - Neoadjuvant Exercise Trial
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
Phase II Palbociclib with Fulvestrant in Individuals with Hormone Receptive Positive HER2 Negative Metastatic Breast Cancer who progressed on treatment with Palbociclib + an Aromatase Inhibitor
CUFF Study: Characterization of Upper Limb Function following Mastectomy and Reconstruction for Breast Cancer
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer
Self-sampling for cancer tests among women in PA: Focus groups
The COVID-19 and Cancer Consortium (CCC19) Registry
NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
EA1181 (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of:The CompassHER2 Trials (COMprehensive use of Pathologic response Assessment to optimize therapy in HER2-positive breast cancer).
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
Disease Team Members
First Name | Last Name | Title | Role | ||
---|---|---|---|---|---|
![]() | Alison | Chetlen | DO | View Researcher Profile | |
![]() | Daleela | Dodge | MD | View Researcher Profile | |
![]() | Rena | Kass | MD | View Researcher Profile | |
![]() | Julie | Mack | MD | View Researcher Profile | |
![]() | Rogerio | Neves | MD, PhD | View Researcher Profile | |
![]() | John | Potochny | MD | View Researcher Profile | |
![]() | Jennifer | Rosenberg | MD | View Researcher Profile | |
![]() | Marc | Rovito | MD | View Researcher Profile | |
![]() | Rebecca | Sivarajah | MD | View Researcher Profile | |
![]() | Cristina | Truica | MD | View Researcher Profile | |
![]() | Kristine | Widders | MD | View Researcher Profile | |
![]() | Nicholas | Zaorsky | MD, MS | View Researcher Profile |
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.
Women In Steady Exercise Research - Neoadjuvant Exercise Trial
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
Phase II Palbociclib with Fulvestrant in Individuals with Hormone Receptive Positive HER2 Negative Metastatic Breast Cancer who progressed on treatment with Palbociclib + an Aromatase Inhibitor
CUFF Study: Characterization of Upper Limb Function following Mastectomy and Reconstruction for Breast Cancer
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer
Self-sampling for cancer tests among women in PA: Focus groups
The COVID-19 and Cancer Consortium (CCC19) Registry
NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
EA1181 (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of:The CompassHER2 Trials (COMprehensive use of Pathologic response Assessment to optimize therapy in HER2-positive breast cancer).
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
First Name | Last Name | Title | Role | ||
---|---|---|---|---|---|
![]() | Alison | Chetlen | DO | View Researcher Profile | |
![]() | Daleela | Dodge | MD | View Researcher Profile | |
![]() | Rena | Kass | MD | View Researcher Profile | |
![]() | Julie | Mack | MD | View Researcher Profile | |
![]() | Rogerio | Neves | MD, PhD | View Researcher Profile | |
![]() | John | Potochny | MD | View Researcher Profile | |
![]() | Jennifer | Rosenberg | MD | View Researcher Profile | |
![]() | Marc | Rovito | MD | View Researcher Profile | |
![]() | Rebecca | Sivarajah | MD | View Researcher Profile | |
![]() | Cristina | Truica | MD | View Researcher Profile | |
![]() | Kristine | Widders | MD | View Researcher Profile | |
![]() | Nicholas | Zaorsky | MD, MS | View Researcher Profile |